CDNA reports Wednesday, Feb 24, 2027, after the close. After the last 4 reports the stock moved +22.2%, +14.7%, −5.1%, −4.1% the next day.
CDNA is expected to report on Wednesday, Feb 24, 2027, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Oct 29, 2026 | 0.26 | 0.70 | +22.2% | +6.7% |
| Jul 30, 2026 | 0.23 | 0.37 | +14.7% | +17.6% |
| Apr 28, 2026 | 0.13 | 0.34 | −5.1% | −5.5% |
| Feb 24, 2026 | 0.23 | 0.12 | −4.1% | −2.3% |
| Nov 4, 2025 | 0.14 | 0.28 | +13.8% | +15.6% |
| Aug 6, 2025 | 0.12 | 0.10 | −7.9% | −7.4% |
| Apr 30, 2025 | 0.07 | 0.10 | −10.7% | −12.5% |
| Feb 26, 2025 | 0.15 | 0.18 | −0.2% | −3.2% |
Average move the next trading day over the last 8 reports: ±9.8% (3 of 8 up).
CDNA is in an uptrend, momentum soft. $80 is the level overhead; $68.6 the first support below.
CDNA at $70.00. Nearest resistance $80.00 (+14.3%). Nearest support $68.60 (−2.0%).
CDNA chart, levels and analysis · Latest analysis: CareDx (CDNA) stock analysis, November 20, 2026: bullish on upside breakout · Earnings this week
CDNA is expected to report on Wednesday, Feb 24, 2027, after the close.
CDNA reports after the close, US Eastern time.
After its report on Oct 29, 2026, CDNA moved +22.2% the next trading day.
Over the last 8 reports, CDNA moved 9.8% on average the next trading day, up 3 times out of 8.
Updated Oct 30, 2026 · Methodology · Research & education, not advice. Dates from company calendars via Yahoo Finance; moves from daily closes.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.